Published in AIDS on June 01, 1988
Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization. J Exp Med (1997) 2.31
Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis. J Exp Med (1989) 1.20
Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160. J Virol (1992) 0.99
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57
Genome organization and transactivation of the human immunodeficiency virus type 2. Nature (1987) 11.79
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science (1984) 10.38
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell (1986) 9.01
Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol (1993) 6.15
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96
HIV-1 genome nuclear import is mediated by a central DNA flap. Cell (2000) 5.87
Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology (1991) 5.54
HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature (1987) 5.45
Single amino-acid changes in HIV envelope affect viral tropism and receptor binding. Nature (1989) 5.12
Human immunodeficiency viruses. Science (1986) 4.34
Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. Science (1984) 4.02
Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature (1998) 4.02
Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light. Lancet (1985) 3.27
Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: results of EVOCAPE 2 multicentre prospective study. Eur J Surg Oncol (2013) 3.24
Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J Virol (1989) 3.05
A possible subunit structure of Rous sarcoma virus RNA. J Gen Virol (1969) 2.96
Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol (1998) 2.94
Molecular cloning and polymorphism of the human immune deficiency virus type 2. Nature (1987) 2.86
Apoptosis in AIDS. Science (1993) 2.86
The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. EMBO J (1987) 2.85
HIV/HTLV gene nomenclature. Nature (1988) 2.72
Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet (1984) 2.56
VPX mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes. EMBO J (1989) 2.45
The cytopathic effect of HIV is associated with apoptosis. Virology (1991) 2.43
The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. AIDS (1988) 2.35
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet (1998) 2.32
Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med (1987) 2.32
Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses (1993) 2.29
Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. Virology (1985) 2.23
Molecular cloning of lymphadenopathy-associated virus. Nature (1985) 2.22
Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol (2001) 2.21
Waterborne outbreak of intestinal microsporidiosis in persons with and without human immunodeficiency virus infection. J Infect Dis (1999) 2.20
Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet (1984) 2.19
Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann Neurol (1992) 2.04
Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding. J Virol (1989) 1.97
Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. Science (1984) 1.95
[Presence of a double chain ribonucleic acid in animal cells]. C R Acad Sci Hebd Seances Acad Sci D (1968) 1.94
Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus). Biochem Biophys Res Commun (1984) 1.94
Characterization of human immunodeficiency virus type 2 envelope glycoproteins: dimerization of the glycoprotein precursor during processing. J Virol (1989) 1.93
Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr (1993) 1.91
A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity. Gene (1990) 1.90
Dendritic cells as the terminal stage of monocyte differentiation. J Immunol (1998) 1.87
Improved antigenicity of the HIV env protein by cleavage site removal. Protein Eng (1988) 1.87
Inactivation, by UV-, x-, and gamma-radiations, of the infecting and transforming capacities of polyoma virus. Virology (1967) 1.86
Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol (1987) 1.81
A rapid and simple colorimetric test for the study of anti-HIV agents. AIDS Res Hum Retroviruses (1988) 1.80
Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors. Proc Natl Acad Sci U S A (1994) 1.78
The multitude and diversity of environmental carcinogens. Environ Res (2007) 1.73
Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. Science (1984) 1.73
Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol (1997) 1.72
AIDS in 1988. Sci Am (1988) 1.71
Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet (1985) 1.70
Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet (1993) 1.68
Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A. Proc Natl Acad Sci U S A (1979) 1.66
Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein. Proc Natl Acad Sci U S A (1999) 1.66
Concomitant infection by human herpesvirus 6, HTLV-I, and HIV-2. Lancet (1988) 1.66
Autoantibodies typical of non-organ-specific autoimmune diseases in HIV-seropositive patients. AIDS (1992) 1.65
Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Proc Natl Acad Sci U S A (2001) 1.65
Disseminated human herpesvirus 6 infection in AIDS. Lancet (1993) 1.64
Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated Factor VIII concentrate. Lancet (1985) 1.60
Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-III. Lancet (1986) 1.58
A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA. AIDS Res Hum Retroviruses (1995) 1.56
The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells. Exp Hematol (1998) 1.51
Human herpesvirus 8 DNA in the skin and blood of patients with Mediterranean Kaposi's sarcoma: clinical correlations. Dermatology (2001) 1.51
Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. N Engl J Med (1984) 1.51
Deficient LAV1 neutralising capacity of sera from patients with AIDS or related syndromes. Lancet (1985) 1.48
High prevalence of human T cell lymphotropic virus type II infection in patients affected by human immunodeficiency virus type 1--associated predominantly sensory polyneuropathy. J Infect Dis (1995) 1.47
Authorship ignorance: views of researchers in French clinical settings. J Med Ethics (2005) 1.46
Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology (1994) 1.46
Early viral replication in the brain of SIV-infected rhesus monkeys. Am J Pathol (1991) 1.42
Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence. Eur J Immunol (1990) 1.40
Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1. J Virol (1990) 1.35
AIDS-associated mycoplasmas. Annu Rev Microbiol (1994) 1.34
Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. J Gen Virol (2001) 1.34
Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression. J Virol (1994) 1.33
Interferon messenger RNA: translation in heterologous cells. Proc Natl Acad Sci U S A (1972) 1.32
Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication. J Exp Med (1988) 1.31
Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed Pharmacother (2007) 1.29
The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication. J Immunol (2001) 1.29
Biosynthesis of mouse interferon by translation of its messenger RNA in a cell-free system. Proc Natl Acad Sci U S A (1975) 1.27
Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann Neurol (1991) 1.26
Molecular evidence for nosocomial transmission of human immunodeficiency virus from a surgeon to one of his patients. J Virol (1998) 1.26
Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers. J Virol (1990) 1.26
A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. J Immunol (1986) 1.25
Kaposi's sarcoma and new herpesvirus. Lancet (1995) 1.24
HIV infection of monocytic cells: rôle of antibody-mediated virus binding to Fc-gamma receptors. AIDS (1989) 1.24
Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry (2008) 1.22